TFBS Bioscience Inc. (TPEX:6939)
Taiwan · Delayed Price · Currency is TWD 20.50
+0.05 (0.24%)
Jun 3, 2026, 11:32 AM CST
TFBS Bioscience Market Cap
TFBS Bioscience has a market cap or net worth of 716.25 million as of June 3, 2026. Its market cap has decreased by -28.77% in one year.
Market Cap
716.25M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
20.50
Market Cap Chart
Since May 15, 2023, TFBS Bioscience's market cap has decreased from 2.35B to 716.25M, a decrease of -69.50%. That is a compound annual growth rate of -32.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 714.51M | -4.44% |
| Dec 31, 2025 | 747.70M | -24.34% |
| Dec 31, 2024 | 988.18M | -39.96% |
| Dec 29, 2023 | 1.65B | -29.93% |
| May 15, 2023 | 2.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.36B |
| DIVA Laboratories | 1.86B |
| Puriblood Medical | 1.08B |
| Genetics Generation Advancement | 1.08B |
| Kim Forest Enterprise | 724.46M |
| Sofiva Genomics | 709.34M |
| Pharmigene | 449.14M |
| Welgene Biotech | 397.34M |